CALIX, INC·4

Nov 6, 1:57 PM ET

Russo Carl 4

4 · CALIX, INC · Filed Nov 6, 2025

Insider Transaction Report

Form 4
Period: 2025-11-04
Russo Carl
Director10% Owner
Transactions
  • Sale

    Common Stock

    2025-11-04$64.00/sh395,000$25,280,0001,719,188 total(indirect: See Footnote)
  • Sale

    Common Stock

    2025-11-04$65.11/sh12,035$783,5841,707,153 total(indirect: See Footnote)
  • Sale

    Common Stock

    2025-11-04$66.47/sh120$7,9761,694,188 total(indirect: See Footnote)
  • Exercise/Conversion

    Common Stock

    2025-11-06$12.63/sh+200,000$2,526,0003,953,070 total
  • Sale

    Common Stock

    2025-11-04$66.00/sh12,845$847,8061,694,308 total(indirect: See Footnote)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-06200,000600,000 total
    Exercise: $12.63Exp: 2030-05-22Common Stock (200,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    13,782
Footnotes (6)
  • [F1]Shares held by The Crescentico Trust, Carl Russo, Trustee.
  • [F2]Sales reported on the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 25, 2025.
  • [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $64.44 to $65.40, inclusive. Full information on the number of shares sold at each sale price is available upon request.
  • [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $65.45 to $66.325, inclusive. Full information on the number of shares sold at each sale price is available upon request.
  • [F5]Shares held by Equanimous Investments. The managing members of Equanimous Investments are Carl Russo and Tim Pasquinelli. These individuals may be deemed to have shared voting and investment power over the shares held by Equanimous Investments. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
  • [F6]100% of the shares subject to the option were fully vested and exercisable on May 22, 2024.

Documents

1 file
  • 4
    wk-form4_1762455426.xmlPrimary

    FORM 4